Make Covid-19 Tests By Private Labs Free, Supreme Court Tells Government
The Supreme Court today asked the government to ensure all tests for Covid-19 infection are conducted free by public and private laboratories.
“We find prima facie substance in the submission of petitioner that at this time of national calamity, permitting private labs to charge Rs 4,500 for screening and confirmation test of Covid-19 may not be within means of a large part of population of this country,” a top court bench of Justice Ashok Bhushan and Justice S Ravindra Bhat said in an interim order. “…and no person [should] be deprived to undergo the Covid-19 test due to non-payment of capped amount of Rs 4,500.”
The court asked the central government to immediately pass directions to enable free testing for all citizens.
Government and private facilities accredited by National Accreditation Board for Test and Calibration Laboratories or agencies approved by the World Health Organisation or Indian Council of Medical Research are allowed to test for the novel coronavirus. The government labs conduct tests for free, while private labs charge for them.
The top court's order came on a petition by a lawyer, Shashank Deo Sudhi, who challenged the March 17 advisory by the ICMR allowing private labs to charge up to Rs 4,500 for a test. He sought free testing given the increasing number of patients. According to the Union Health Ministry, India has reported 5,274 confirmed Covid-19 cases, including 149 deaths and 410 who have been cured.
The Supreme Court suggested that the government can come up with a mechanism where the private laboratories can be reimbursed for these tests, instead of making the citizens for it.
“The question as to whether the private Laboratories carrying free of cost Covid-19 tests are entitled for any reimbursement of expenses incurred shall be considered later,” the top court said. It gave the government two weeks to file its reply.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.